I read this artible about a couple weeks ago and have been meanting to post this to see if anyone knows of any trials. Or might be in any trials regarding this. A snippet from the article.
Now, in the latest study, the researchers further evaluated one derivative, ErSO-TFPy, and found that it:
Effectively killed multiple human ER+ breast cancer cell lines in culture.
Was well tolerated, with no obvious deleterious effects, by multiple species (mice, rats and beagles).
Shrank transplanted human breast tumors of various genetic backgrounds in mice.
for those interested here is the article I read.